# Mechanisms Responsible for Cardiac and Skeletal Muscle Energetic Impairment in Diabetes

> **NCT00628056** · PHASE1,PHASE2 · UNKNOWN · sponsor: **University Hospital Birmingham** · enrollment: 75 (estimated)

## Conditions studied

- Diabetic Cardiomyopathy

## Interventions

- **DRUG:** Perhexiline

## Key facts

- **NCT ID:** NCT00628056
- **Lead sponsor:** University Hospital Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-10
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2008-03-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00628056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00628056, "Mechanisms Responsible for Cardiac and Skeletal Muscle Energetic Impairment in Diabetes". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00628056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*